Simplex Trading
TBIO

Simplex Trading’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Simplex Trading’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,834
Closed -$315K – 10501
2020
Q4 		$254K Buy
13,834
+395
+3% +$7.07K ﹤0.01% 4294
2020
Q3 		$182K Sell
13,439
-8,848
-40% -$136K ﹤0.01% 4234
2020
Q2 		$399K Buy
+22,287
New +$336K ﹤0.01% 3187

Simplex Trading's TBIO Position: Q1 2021 in Review

Simplex Trading sold out of Translate Bio, Inc. Common Stock (TBIO) in Q1 2021, closing a stake of 13,834 shares — an estimated $315K sold.

Simplex Trading first reported a position in TBIO in Q2 2020 and held it in 3 quarters. The position peaked at $399K in Q2 2020. 146 funds tracked by Wall St. Rank hold TBIO as of Q1 2021.

  • Simplex Trading reported no remaining Translate Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Simplex Trading sold 13,834 Translate Bio, Inc. Common Stock shares in Q1 2021, an estimated $315K.
  • Simplex Trading first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • Simplex Trading's Translate Bio, Inc. Common Stock position peaked at $399K in Q2 2020.
  • 146 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2021.

Based on Simplex Trading's 13F filing for Q1 2021, filed 26 Apr 2021.